Barclays’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.33K | Hold |
|
|||||
|
2025
Q2 | $4K | Hold |
|
|||||
|
2025
Q1 | $5K | Hold |
|
|||||
|
2024
Q4 | $7K | Hold |
|
|||||
|
2024
Q3 | $5K | Sell |
|
|||||
|
2024
Q2 | $22K | Sell |
|
|||||
|
2024
Q1 | $59K | Sell |
|
|||||
|
2023
Q4 | $146K | Buy |
|
|||||
|
2023
Q3 | $28K | Sell |
|
|||||
|
2023
Q2 | $48K | Buy |
|
|||||
|
2023
Q1 | $22K | Hold |
|
|||||
|
2022
Q4 | $17K | Sell |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $18K | Sell |
|
|||||
|
2022
Q1 | $60K | Sell |
|
|||||
|
2021
Q4 | $503K | Buy |
|
|||||
|
2021
Q3 | $288K | Buy |
|
|||||
|
2021
Q2 | $66K | Sell |
|
|||||
|
2021
Q1 | $302K | Buy |
|
|||||
|
2020
Q4 | $166K | Sell |
|
|||||
|
2020
Q3 | $286K | Buy |
|
|||||
|
2020
Q2 | $381K | Buy |
|
|||||
|
2020
Q1 | $94K | Sell |
|
|||||
|
2019
Q4 | $317K | Buy |
|
|||||
|
2019
Q3 | $120K | Buy |
|
|||||
|
2019
Q2 | $105K | Buy |
|
|||||
|
2019
Q1 | $40K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $60K | Buy |
|
|||||
|
2018
Q2 | $15K | Sell |
|
|||||
|
2018
Q1 | $26K | Buy |
|